PDB Short entry for 1SHL HEADER HYDROLASE 25-FEB-04 1SHL TITLE CASPASE-7 IN COMPLEX WITH FICA ALLOSTERIC INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-7; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ICE-LIKE APOPTOTIC PROTEASE 3, ICE-LAP3, APOPTOTIC PROTEASE COMPND 5 MCH-3, CMH-1; COMPND 6 EC: 3.4.22.-; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP7, MCH3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PJH07, PJH08; SOURCE 11 OTHER_DETAILS: CASPASE-7 LARGE AND SMALL SUBUNITS WERE CO-EXPRESSED SOURCE 12 FROM TWO SEPARATE PLASMIDS , YIELDING A LARGE SUBUNIT OF RESIDUES SOURCE 13 57-199 AND A SMALL SUBUNIT OF RESIDUES 21 0-303 WITH THE ADDITION OF SOURCE 14 EIGHT AMINO ACIDS QLHHHHHH. KEYWDS CASPASE, PROTEASE, CYSTEINE PROTEASE, ALLOSTERIC, CENTRAL-CAVITY, KEYWDS 2 DIMER INTERFACE, INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.A.HARDY,J.LAM,J.T.NGUYEN,T.O'BRIEN,J.A.WELLS REVDAT 6 23-AUG-23 1SHL 1 REMARK REVDAT 5 27-OCT-21 1SHL 1 REMARK SEQADV LINK REVDAT 4 23-AUG-17 1SHL 1 SOURCE REMARK REVDAT 3 24-FEB-09 1SHL 1 VERSN REVDAT 2 07-SEP-04 1SHL 1 JRNL REVDAT 1 17-AUG-04 1SHL 0 JRNL AUTH J.A.HARDY,J.LAM,J.T.NGUYEN,T.O'BRIEN,J.A.WELLS JRNL TITL DISCOVERY OF AN ALLOSTERIC SITE IN THE CASPASES JRNL REF PROC.NATL.ACAD.SCI.USA V. 101 12461 2004 JRNL REFN ISSN 0027-8424 JRNL PMID 15314233 JRNL DOI 10.1073/PNAS.0404781101 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.19 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 16639 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 897 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.10 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1505 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2950 REMARK 3 BIN FREE R VALUE SET COUNT : 88 REMARK 3 BIN FREE R VALUE : 0.3250 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3164 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 75.82 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.45000 REMARK 3 B22 (A**2) : 3.45000 REMARK 3 B33 (A**2) : -5.18000 REMARK 3 B12 (A**2) : 1.73000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.611 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.366 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.274 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.338 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.920 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.879 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3243 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4356 ; 1.297 ; 1.960 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 390 ; 5.990 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 483 ; 0.086 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2414 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1321 ; 0.222 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 88 ; 0.117 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 17 ; 0.217 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.148 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1967 ; 2.160 ; 2.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3159 ; 3.829 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1276 ; 2.226 ; 2.500 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1197 ; 3.503 ; 5.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 5 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 59 A 148 4 REMARK 3 1 B 59 B 148 4 REMARK 3 2 A 149 A 184 4 REMARK 3 2 B 149 B 184 4 REMARK 3 3 A 218 A 225 6 REMARK 3 3 B 218 B 225 6 REMARK 3 4 A 239 A 271 4 REMARK 3 4 B 239 B 271 4 REMARK 3 5 A 288 A 303 4 REMARK 3 5 B 288 B 303 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1382 ; 0.46 ; 0.50 REMARK 3 LOOSE POSITIONAL 1 A (A): 68 ; 0.56 ; 5.00 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1382 ; 0.77 ; 2.00 REMARK 3 LOOSE THERMAL 1 A (A**2): 68 ; 3.34 ; 10.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1SHL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-FEB-04. REMARK 100 THE DEPOSITION ID IS D_1000021712. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JAN-03 REMARK 200 TEMPERATURE (KELVIN) : 93.0 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8856 REMARK 200 MONOCHROMATOR : MONOCHROMATOR REMARK 200 OPTICS : BEAMLINE 9-1 STANDARD REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : MOSFLM REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18022 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 21.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.8900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.46000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1K88 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CITRATE, LITHIUM SULFATE, SODIUM REMARK 280 CHLORIDE, PH 5.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 124.41400 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.20700 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.20700 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 124.41400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 187 REMARK 465 GLY A 188 REMARK 465 THR A 189 REMARK 465 GLU A 190 REMARK 465 LEU A 191 REMARK 465 ALA A 192 REMARK 465 ASP A 193 REMARK 465 GLY A 194 REMARK 465 ILE A 195 REMARK 465 GLN A 196 REMARK 465 ALA A 197 REMARK 465 ASP A 198 REMARK 465 SER A 199 REMARK 465 ARG A 210 REMARK 465 TYR A 211 REMARK 465 LYS A 212 REMARK 465 PRO A 227 REMARK 465 GLY A 228 REMARK 465 TYR A 229 REMARK 465 TYR A 230 REMARK 465 SER A 231 REMARK 465 TRP A 232 REMARK 465 ARG A 233 REMARK 465 SER A 234 REMARK 465 PRO A 235 REMARK 465 GLY A 236 REMARK 465 GLU A 274 REMARK 465 SER A 275 REMARK 465 GLN A 276 REMARK 465 SER A 277 REMARK 465 ASP A 278 REMARK 465 ASP A 279 REMARK 465 PRO A 280 REMARK 465 HIS A 281 REMARK 465 PHE A 282 REMARK 465 HIS A 283 REMARK 465 GLU A 284 REMARK 465 LYS A 285 REMARK 465 LYS A 286 REMARK 465 GLN A 304 REMARK 465 LEU A 305 REMARK 465 HIS A 306 REMARK 465 HIS A 307 REMARK 465 HIS A 308 REMARK 465 HIS A 309 REMARK 465 HIS A 310 REMARK 465 HIS A 311 REMARK 465 THR B 189 REMARK 465 GLU B 190 REMARK 465 LEU B 191 REMARK 465 ALA B 192 REMARK 465 ASP B 193 REMARK 465 GLY B 194 REMARK 465 ILE B 195 REMARK 465 GLN B 196 REMARK 465 ALA B 197 REMARK 465 ASP B 198 REMARK 465 SER B 199 REMARK 465 ARG B 210 REMARK 465 TYR B 211 REMARK 465 LYS B 212 REMARK 465 GLY B 228 REMARK 465 TYR B 229 REMARK 465 TYR B 230 REMARK 465 SER B 231 REMARK 465 TRP B 232 REMARK 465 ARG B 233 REMARK 465 SER B 234 REMARK 465 PRO B 235 REMARK 465 GLY B 236 REMARK 465 ARG B 237 REMARK 465 GLU B 274 REMARK 465 SER B 275 REMARK 465 GLN B 276 REMARK 465 SER B 277 REMARK 465 ASP B 278 REMARK 465 ASP B 279 REMARK 465 PRO B 280 REMARK 465 HIS B 281 REMARK 465 PHE B 282 REMARK 465 HIS B 283 REMARK 465 GLU B 284 REMARK 465 LYS B 285 REMARK 465 LYS B 286 REMARK 465 GLN B 304 REMARK 465 LEU B 305 REMARK 465 HIS B 306 REMARK 465 HIS B 307 REMARK 465 HIS B 308 REMARK 465 HIS B 309 REMARK 465 HIS B 310 REMARK 465 HIS B 311 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLY A 155 O REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 172 CG CD CE NZ REMARK 480 GLN A 287 CG CD OE1 NE2 REMARK 480 LYS B 92 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LYS A 172 CB LYS A 172 CG -0.243 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 130 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 GLN A 287 CA - CB - CG ANGL. DEV. = -23.3 DEGREES REMARK 500 CYS A 290 O - C - N ANGL. DEV. = -10.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 74 75.47 -119.62 REMARK 500 LYS A 80 -53.63 -13.10 REMARK 500 VAL A 81 12.60 -64.03 REMARK 500 SER A 143 -166.46 -160.12 REMARK 500 GLU A 146 -89.78 -110.49 REMARK 500 ASN A 148 33.14 -155.82 REMARK 500 ASP A 154 33.06 -89.67 REMARK 500 ARG A 167 175.65 -56.43 REMARK 500 ASP A 169 -32.80 -133.64 REMARK 500 PRO A 214 -160.64 -107.96 REMARK 500 GLU A 216 149.91 149.91 REMARK 500 PHE A 301 32.35 -87.45 REMARK 500 SER B 143 -167.20 -162.80 REMARK 500 GLU B 147 122.56 -34.84 REMARK 500 ASN B 148 12.07 54.43 REMARK 500 PHE B 166 45.55 -99.64 REMARK 500 PRO B 214 75.01 -103.79 REMARK 500 SER B 302 -165.09 -103.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ILE A 213 PRO A 214 31.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 CYS B 290 -16.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FXN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FXN B 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SHJ RELATED DB: PDB REMARK 900 CASPASE-7 COMPLEXED WITH DICA INHIBITOR DBREF 1SHL A 57 199 UNP P55210 CASP7_HUMAN 57 199 DBREF 1SHL A 210 303 UNP P55210 ICE7_HUMAN 210 303 DBREF 1SHL B 57 199 UNP P55210 CASP7_HUMAN 57 199 DBREF 1SHL B 210 303 UNP P55210 ICE7_HUMAN 210 303 SEQADV 1SHL ALA A 192 UNP P55210 ASP 192 ENGINEERED MUTATION SEQADV 1SHL GLN A 304 UNP P55210 EXPRESSION TAG SEQADV 1SHL LEU A 305 UNP P55210 EXPRESSION TAG SEQADV 1SHL HIS A 306 UNP P55210 EXPRESSION TAG SEQADV 1SHL HIS A 307 UNP P55210 EXPRESSION TAG SEQADV 1SHL HIS A 308 UNP P55210 EXPRESSION TAG SEQADV 1SHL HIS A 309 UNP P55210 EXPRESSION TAG SEQADV 1SHL HIS A 310 UNP P55210 EXPRESSION TAG SEQADV 1SHL HIS A 311 UNP P55210 EXPRESSION TAG SEQADV 1SHL ALA B 192 UNP P55210 ASP 192 ENGINEERED MUTATION SEQADV 1SHL GLN B 304 UNP P55210 EXPRESSION TAG SEQADV 1SHL LEU B 305 UNP P55210 EXPRESSION TAG SEQADV 1SHL HIS B 306 UNP P55210 EXPRESSION TAG SEQADV 1SHL HIS B 307 UNP P55210 EXPRESSION TAG SEQADV 1SHL HIS B 308 UNP P55210 EXPRESSION TAG SEQADV 1SHL HIS B 309 UNP P55210 EXPRESSION TAG SEQADV 1SHL HIS B 310 UNP P55210 EXPRESSION TAG SEQADV 1SHL HIS B 311 UNP P55210 EXPRESSION TAG SEQRES 1 A 245 THR TYR GLN TYR ASN MET ASN PHE GLU LYS LEU GLY LYS SEQRES 2 A 245 CYS ILE ILE ILE ASN ASN LYS ASN PHE ASP LYS VAL THR SEQRES 3 A 245 GLY MET GLY VAL ARG ASN GLY THR ASP LYS ASP ALA GLU SEQRES 4 A 245 ALA LEU PHE LYS CYS PHE ARG SER LEU GLY PHE ASP VAL SEQRES 5 A 245 ILE VAL TYR ASN ASP CYS SER CYS ALA LYS MET GLN ASP SEQRES 6 A 245 LEU LEU LYS LYS ALA SER GLU GLU ASP HIS THR ASN ALA SEQRES 7 A 245 ALA CYS PHE ALA CYS ILE LEU LEU SER HIS GLY GLU GLU SEQRES 8 A 245 ASN VAL ILE TYR GLY LYS ASP GLY VAL THR PRO ILE LYS SEQRES 9 A 245 ASP LEU THR ALA HIS PHE ARG GLY ASP ARG CYS LYS THR SEQRES 10 A 245 LEU LEU GLU LYS PRO LYS LEU PHE PHE ILE GLN ALA CYS SEQRES 11 A 245 ARG GLY THR GLU LEU ALA ASP GLY ILE GLN ALA ASP SER SEQRES 12 A 245 ARG TYR LYS ILE PRO VAL GLU ALA ASP PHE LEU PHE ALA SEQRES 13 A 245 TYR SER THR VAL PRO GLY TYR TYR SER TRP ARG SER PRO SEQRES 14 A 245 GLY ARG GLY SER TRP PHE VAL GLN ALA LEU CYS SER ILE SEQRES 15 A 245 LEU GLU GLU HIS GLY LYS ASP LEU GLU ILE MET GLN ILE SEQRES 16 A 245 LEU THR ARG VAL ASN ASP ARG VAL ALA ARG HIS PHE GLU SEQRES 17 A 245 SER GLN SER ASP ASP PRO HIS PHE HIS GLU LYS LYS GLN SEQRES 18 A 245 ILE PRO CYS VAL VAL SER MET LEU THR LYS GLU LEU TYR SEQRES 19 A 245 PHE SER GLN GLN LEU HIS HIS HIS HIS HIS HIS SEQRES 1 B 245 THR TYR GLN TYR ASN MET ASN PHE GLU LYS LEU GLY LYS SEQRES 2 B 245 CYS ILE ILE ILE ASN ASN LYS ASN PHE ASP LYS VAL THR SEQRES 3 B 245 GLY MET GLY VAL ARG ASN GLY THR ASP LYS ASP ALA GLU SEQRES 4 B 245 ALA LEU PHE LYS CYS PHE ARG SER LEU GLY PHE ASP VAL SEQRES 5 B 245 ILE VAL TYR ASN ASP CYS SER CYS ALA LYS MET GLN ASP SEQRES 6 B 245 LEU LEU LYS LYS ALA SER GLU GLU ASP HIS THR ASN ALA SEQRES 7 B 245 ALA CYS PHE ALA CYS ILE LEU LEU SER HIS GLY GLU GLU SEQRES 8 B 245 ASN VAL ILE TYR GLY LYS ASP GLY VAL THR PRO ILE LYS SEQRES 9 B 245 ASP LEU THR ALA HIS PHE ARG GLY ASP ARG CYS LYS THR SEQRES 10 B 245 LEU LEU GLU LYS PRO LYS LEU PHE PHE ILE GLN ALA CYS SEQRES 11 B 245 ARG GLY THR GLU LEU ALA ASP GLY ILE GLN ALA ASP SER SEQRES 12 B 245 ARG TYR LYS ILE PRO VAL GLU ALA ASP PHE LEU PHE ALA SEQRES 13 B 245 TYR SER THR VAL PRO GLY TYR TYR SER TRP ARG SER PRO SEQRES 14 B 245 GLY ARG GLY SER TRP PHE VAL GLN ALA LEU CYS SER ILE SEQRES 15 B 245 LEU GLU GLU HIS GLY LYS ASP LEU GLU ILE MET GLN ILE SEQRES 16 B 245 LEU THR ARG VAL ASN ASP ARG VAL ALA ARG HIS PHE GLU SEQRES 17 B 245 SER GLN SER ASP ASP PRO HIS PHE HIS GLU LYS LYS GLN SEQRES 18 B 245 ILE PRO CYS VAL VAL SER MET LEU THR LYS GLU LEU TYR SEQRES 19 B 245 PHE SER GLN GLN LEU HIS HIS HIS HIS HIS HIS HET FXN A 401 16 HET FXN B 401 16 HETNAM FXN 5-FLUORO-1H-INDOLE-2-CARBOXYLIC ACID-(2-MERCAPTO- HETNAM 2 FXN ETHYL)-AMIDE HETSYN FXN FICA FORMUL 3 FXN 2(C11 H11 F N2 O S) HELIX 1 1 ASP A 79 GLY A 83 5 5 HELIX 2 2 GLY A 89 GLY A 105 1 17 HELIX 3 3 SER A 115 GLU A 129 1 15 HELIX 4 4 ILE A 159 ALA A 164 1 6 HELIX 5 5 HIS A 165 ARG A 167 5 3 HELIX 6 6 SER A 239 GLY A 253 1 15 HELIX 7 7 GLU A 257 PHE A 273 1 17 HELIX 8 8 ASP B 79 GLY B 83 5 5 HELIX 9 9 GLY B 89 GLY B 105 1 17 HELIX 10 10 SER B 115 GLU B 128 1 14 HELIX 11 11 ILE B 159 HIS B 165 1 7 HELIX 12 12 CYS B 171 LEU B 175 5 5 HELIX 13 13 SER B 239 GLY B 253 1 15 HELIX 14 14 GLU B 257 HIS B 272 1 16 SHEET 1 A12 ASP A 107 ASN A 112 0 SHEET 2 A12 LYS A 69 ASN A 74 1 N ASN A 74 O TYR A 111 SHEET 3 A12 PHE A 137 HIS A 144 1 O LEU A 142 N ILE A 73 SHEET 4 A12 LYS A 179 CYS A 186 1 O LEU A 180 N CYS A 139 SHEET 5 A12 PHE A 219 SER A 224 1 O LEU A 220 N PHE A 181 SHEET 6 A12 CYS A 290 SER A 293 -1 O VAL A 292 N PHE A 221 SHEET 7 A12 CYS B 290 SER B 293 -1 O VAL B 291 N SER A 293 SHEET 8 A12 PHE B 219 SER B 224 -1 N PHE B 221 O VAL B 292 SHEET 9 A12 LYS B 179 ALA B 185 1 N PHE B 181 O ALA B 222 SHEET 10 A12 ALA B 134 SER B 143 1 N LEU B 141 O GLN B 184 SHEET 11 A12 LYS B 66 ASN B 74 1 N ILE B 71 O ILE B 140 SHEET 12 A12 ASP B 107 ASN B 112 1 O TYR B 111 N ASN B 74 SHEET 1 B 2 VAL A 149 ILE A 150 0 SHEET 2 B 2 THR A 157 PRO A 158 -1 O THR A 157 N ILE A 150 SHEET 1 C 3 GLY B 145 GLU B 146 0 SHEET 2 C 3 VAL B 149 TYR B 151 -1 O VAL B 149 N GLU B 146 SHEET 3 C 3 VAL B 156 PRO B 158 -1 O THR B 157 N ILE B 150 LINK SG CYS A 290 S19 FXN A 401 1555 1555 2.02 LINK SG CYS B 290 S19 FXN B 401 1555 1555 2.03 SITE 1 AC1 7 CYS A 290 ILE B 183 PRO B 214 PHE B 221 SITE 2 AC1 7 TYR B 223 VAL B 292 FXN B 401 SITE 1 AC2 8 ILE A 159 ILE A 183 PHE A 221 TYR A 223 SITE 2 AC2 8 VAL A 292 FXN A 401 CYS B 290 VAL B 292 CRYST1 90.220 90.220 186.621 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011084 0.006399 0.000000 0.00000 SCALE2 0.000000 0.012799 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005358 0.00000